Home

Minimize win Think randomized double blind Engineers outer Description

What is a Double-Blind Trial?
What is a Double-Blind Trial?

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte  Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia: Molecular Therapy

Is it proven by randomised, double-blind, placebo-controlled clinical  trials?”
Is it proven by randomised, double-blind, placebo-controlled clinical trials?”

8. 7 Randomised, double-blind, placebo-controlled trials | Training manual  | HIV i-Base
8. 7 Randomised, double-blind, placebo-controlled trials | Training manual | HIV i-Base

Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of  Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive  Bladder - European Urology Focus
Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder - European Urology Focus

A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of  Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis - Khanna - 2023  - Arthritis & Rheumatology - Wiley Online Library
A 24‐Week, Phase IIa, Randomized, Double‐Blind, Placebo‐Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis - Khanna - 2023 - Arthritis & Rheumatology - Wiley Online Library

A phase 1, randomized double-blind, placebo controlled trial to evaluate  safety and efficacy of epigallocatechin-3-gallate and cognitive training in  adults with Fragile X syndrome - ScienceDirect
A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome - ScienceDirect

Design of the randomized, double-blind, controlled, cross-over study in...  | Download Scientific Diagram
Design of the randomized, double-blind, controlled, cross-over study in... | Download Scientific Diagram

Phase 2, randomized, double-blind, placebo-controlled multi-center trial of  the clinical and biological effects of anti-CD14 treatment in hospitalized  patients with COVID-19 pneumonia - eBioMedicine
Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia - eBioMedicine

Study design. A randomized, double-blind, placebo-controlled, crossover...  | Download Scientific Diagram
Study design. A randomized, double-blind, placebo-controlled, crossover... | Download Scientific Diagram

Schematic representation of double-blind, randomized, controlled,... |  Download Scientific Diagram
Schematic representation of double-blind, randomized, controlled,... | Download Scientific Diagram

Aspire: A 52-week, Muticenter, Randomized, Double-blind, Placebo-controlled  Study to Evaluate the Efficacy, Safety, & Tolerability of an Intramuscular  Depot Formulation of Aripiprazole (OPC-14597) As Maintenance Treatment in  Patients w/ Schizophrenia ...
Aspire: A 52-week, Muticenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, & Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) As Maintenance Treatment in Patients w/ Schizophrenia ...

A randomized, double-blind, placebo-controlled, dose-escalating phase I  trial to evaluate safety and immunogenicity of a plant-produced, bivalent,  recombinant norovirus-like particle vaccine
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine

A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of  Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute  Schizophrenia: Lessons Learned - MedWorks Media
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned - MedWorks Media

ELAMIPRETIDE IN PATIENTS WITH BARTH SYNDROME: A RANDOMIZED, DOUBLE-BLIND,  PLACEBO-CONTROLLED CLINICAL TRIAL FOLLOWED BY 36-WEEK OPEN-LABEL EXTENSION  | Journal of the American College of Cardiology
ELAMIPRETIDE IN PATIENTS WITH BARTH SYNDROME: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL FOLLOWED BY 36-WEEK OPEN-LABEL EXTENSION | Journal of the American College of Cardiology

Randomised trials | Cancer Research UK
Randomised trials | Cancer Research UK

Blood Journal on X: "A randomized double-blind trial of 3 aspirin regimens  to optimize antiplatelet therapy in essential thrombocythemia  https://t.co/lJNxpqQqXK https://t.co/7OcnMKLAjT" / X
Blood Journal on X: "A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia https://t.co/lJNxpqQqXK https://t.co/7OcnMKLAjT" / X

Answered: In randomized, double-blind clinical… | bartleby
Answered: In randomized, double-blind clinical… | bartleby

A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled,  Parallel-group Study of 2 Dosing Regimens of Fostamatinib in Patients with  Rheumatoid Arthritis with an Inadequate Response to a Tumor Necrosis  Factor-α Antagonist | The
A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of 2 Dosing Regimens of Fostamatinib in Patients with Rheumatoid Arthritis with an Inadequate Response to a Tumor Necrosis Factor-α Antagonist | The

UKidney - A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of  Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis  Hyperkalemia
UKidney - A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia

The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older  Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial | The  Hearing Review
The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial | The Hearing Review

Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+  levels in humans safely and sustainably: a randomized, double-blind,  placebo-controlled study | npj Aging
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study | npj Aging